HAE logo
Haemonetics Corporation(HAE)
Last print unknown agoAbout this dataData status
$118.73▲0.45 (0.38%)Stale · unknown old

HAE Retained Earnings

$311.52MQuarterly · USD

Period ending:

HAE FY Retained EarningsUSD
HAE FY Retained Earnings1992-03-31: $57.00M1993-03-31: $81.70M1994-03-31: $113.20M1995-03-31: $146.80M1996-03-31: $182.70M1997-03-31: $215.70M1998-03-31: $190.80M1999-03-31: $211.80M2000-03-31: $230.73M2001-03-31: $234.33M2002-03-31: $264.59M2003-03-31: $292.97M2004-03-31: $322.29M2005-03-31: $233.77M2006-03-31: $302.85M2007-03-31: $315.77M2008-03-31: $302.20M2009-03-31: $309.52M2010-03-31: $334.64M2011-03-31: $373.63M2012-03-31: $400.78M2013-03-31: $398.20M2014-03-31: $433.35M2015-03-31: $420.37M2016-03-31: $316.18M2017-03-31: $289.92M2018-03-31: $266.94M2019-03-31: $161.42M2020-03-31: $78.51M2021-03-31: $157.98M2022-03-31: $202.39M2023-03-31: $253.17M2024-03-31: $360.46M2025-03-29: $352.17M2026-03-28: $279.34M$433.35M$0.00
1992-03-312026-03-28

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

HAE retained earnings history

Cumulative earnings retained in the business. The available annual fiscal periods series contains 35 observations from Mar 31, 1992 to Mar 28, 2026.

Haemonetics Corp Retained Earnings — Annual fiscal periods (USD)
Period endingRetained Earnings (USD)
279,344,000
352,174,000
360,456,000
253,168,000
202,391,000
157,981,000
78,512,000
161,418,000
266,942,000
289,916,000
316,184,000
420,365,000
433,347,000
398,199,000
400,783,000
373,630,000
334,641,000
309,516,000
302,196,000
315,767,000
302,845,000
233,769,000
322,291,000
292,971,000
264,592,000
234,325,000
230,732,000
211,800,000
190,800,000
215,700,000
182,700,000
146,800,000
113,200,000
81,700,000
57,000,000

Compare retained earnings

All HAE financial metrics · HAE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.